Publication | Open Access

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

ObesityMetabolic SyndromeNon-pharmacological InterventionHeart FailureCardiovascular DiseaseHealth PolicyDiabetesCardiovascular PharmacologyClinical TrialsSemaglutide Versus PlaceboObesity ManagementCardiac CareObesity-related Heart FailureStep-hfpef DmMedicineCardiologyAnesthesiologyHealth Sciences